GoHealth Overview
GoHealth (GOCO) has a ROE of -13603.43%, below the Finance sector average of 14.93%.
Get informed when a big investor buys or sells
+ Follow-13603.43%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for GOCO is -13603.43%. That is below the Finance sector average of 14.93%. Investors often review this figure alongside GoHealth's historical trend and sector peers before judging valuation or financial health.
Against Finance companies, GOCO currently prints -13603.43% for ROE, while the sector average sits near 14.93%. That is roughly 91242.4% below the sector mean. Large gaps often invite a closer look at GoHealth's growth, margins, and balance sheet.
Return on Equity shows how effectively GoHealth converts resources into returns. At -13603.43%, GOCO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GOCO's ROE (-13603.43%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack GoHealth's ROE against similar Finance names. You can also browse sector and industry screens on Stockcircle for a broader set of Finance companies and their key multiples and fundamentals.
